SHERIDAN, WYOMING – March 20, 2025 - A New Strategic Alliance Strengthens Access to Advanced Bone Graft Materials Across Europe
Two major players in the field of dental innovation—BEGO Implant Systems and NovaBone—have announced a strategic partnership aimed at transforming the European dental regeneration market. Under this agreement, BEGO Implant Systems will manage the European distribution of NovaBone’s bone graft substitute products, marking a significant step toward improved accessibility and treatment quality for dental professionals and patients alike.
This new alliance brings together BEGO’s deep-rooted expertise in implantology and distribution with NovaBone’s proven leadership in bone regeneration materials, offering enhanced value to the rapidly growing implant dentistry sector.
Elevating Regenerative Care Through Strategic Collaboration
Improving accessibility to bone regeneration products has become an increasing priority in modern dental implantology. This collaboration directly supports that goal by expanding availability of NovaBone’s biocompatible and clinically proven materials throughout Europe.
"The partnership with NovaBone expands our portfolio in the field of dental regeneration materials and offers our customers an even broader range of solutions for implant restoration," explains Steffen Böhm, Chief Product Officer, BEGO Group. "We look forward to combining NovaBone’s expertise with our comprehensive distribution structure to further enhance the quality of treatment for patients."
Merging Innovation with Market Expertise
NovaBone, based in the United States, has earned global recognition for its advanced, easy-to-use bone graft technologies that support optimal healing and bone regeneration. The company’s confidence in the new partnership highlights BEGO’s strong European market presence and reputation for quality.
"With BEGO Implant Systems, we have a partner at our side who not only has extensive market knowledge, but also enjoys an excellent reputation for high-quality products and innovative solutions," says Scott Day, NovaBone spokesperson.
This strategic collaboration allows both companies to deliver greater value to dental practices by providing integrated access to regeneration materials and implant systems through a single, trusted supplier.
A Win-Win for Clinicians and Patients
Dental professionals across Europe will benefit from simplified procurement and broader access to regenerative products that are backed by clinical evidence and advanced manufacturing standards. NovaBone’s materials are engineered to promote rapid healing, support long-term stability, and integrate easily into diverse clinical workflows.
Meanwhile, BEGO’s robust sales and distribution infrastructure ensures these solutions are delivered promptly and reliably, supporting both private practices and institutional providers.
The alliance aims to drive higher standards in treatment outcomes while making regenerative care more accessible to a growing patient base.
A Lasting Impact on the Regenerative Dentistry Market
By aligning their complementary strengths, BEGO and NovaBone are poised to influence the future of dental regeneration across Europe. The partnership not only expands product access but also underscores both companies’ commitment to innovation, patient care, and professional support.
Both firms agree that this is only the beginning of a long-term collaboration that will benefit users and patients alike.
Call to Action:
To learn more about the products and partnership, visit:
🔗 BEGO Implant Systems
🔗 NovaBone